The pharmaceutical manufacturing industry in Latin America plays a crucial role in meeting health care needs across the region. It comprises a variety of players, ranging from large multinational corporations to agile local startups. These companies produce a wide array of products, including generic drugs, vaccines, and biotechnology solutions. With growing investment in research and development, the sector is evolving rapidly, introducing innovative therapies and increasing production capacities. Emerging opportunities lie in personalized medicine and technology-driven therapies, positioning Latin America as an increasingly important player in the global pharmaceutical arena.


This list highlights 17 key investors in the Latin American pharmaceutical manufacturing sector. The investors range from venture capital firms to private equity, with a mix of local and regionally-focused firms. Most investors are headquartered in Brazil, followed by Chile and Mexico. Operating in sizes varying from small teams to medium-sized companies, their founding years span over two decades, reflecting a blend of seasoned and newer firms. In 2024, these investors actively participated in a collective total of 107 deals, emphasizing their strong commitment to supporting pharmaceutical innovation.


Top 17 Pharmaceutical Manufacturing Investors in Latin America


1. bossa invest

  • Website: bossainvest.com
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2011
  • Headcount: 11-50
  • Number of deals in 2024: 56
  • LinkedIn: bossainvest

Bossa Invest is a venture capital firm based in Sao Paulo, Brazil, founded in 2011. The firm specializes in investing in innovative startups, particularly in the technology sector, but has also shown a significant interest in the pharmaceutical and biotechnology industries. In 2020, Bossa Invest participated in seed rounds for companies like Gilgamesh Pharmaceuticals and Altay Therapeutics, which are focused on pharmaceutical development. Additionally, they have invested in Gen1E Lifesciences, further emphasizing their engagement in the life sciences sector. Bossa Invest not only provides capital but also offers strategic guidance and access to a network of co-investors, aiming to empower entrepreneurs and foster growth in the startup ecosystem, including those in the pharmaceutical manufacturing field.


2. Kptl

  • Website: kptl.com.br
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2020
  • Headcount: 11-50
  • Number of deals in 2024: 5
  • LinkedIn: inseed-investimentos

KPTL is a venture capital firm based in Sao Paulo, Brazil, founded in 2020. With over 15 years of experience, KPTL has made more than 124 investments, focusing on innovative startups across various sectors. Among their notable transactions, Kptl invested in Ages Bioactive, which raised $1,474,845 in a venture round in July 2022, and Vida Biotecnologia, which received funding in 2012. These investments highlight Kptl's engagement in the pharmaceutical and biotechnology sectors, showcasing their commitment to supporting companies that contribute to advancements in healthcare and pharmaceuticals.


3. The Ganesha Lab

  • Website: theganeshalab.com
  • Type: Corporate
  • Headquarters: Las Condes, Santiago, Chile
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 5
  • LinkedIn: ganeshalab

The Ganesha Lab is a biotech accelerator based in Las Condes, Santiago, Chile, founded in 2016. It supports early-stage biotech startups in Latin America through various programs such as BIGinBIO and Scale Up. The Ganesha Lab provides mentorship, workshops, and access to funding, helping startups navigate the complexities of the biotech industry and scale their innovations for global impact. Notable transactions include investments in companies like Botanical Solutions, which raised $3.3 million in a Seed Round, and Pannex Therapeutics Inc., which raised funds in a Pre-Seed Round. These transactions highlight their active role in supporting biotech ventures that may contribute to pharmaceutical manufacturing.


4. GRIDS Capital

  • Website: gridscapital.com
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 1
  • LinkedIn: grids-capital

GRIDS Capital is a venture capital firm based in Sao Paulo, Brazil, founded in 2016. The firm specializes in deep tech ventures and provides investment and market analysis services to entrepreneurs and businesses in advanced technology sectors. GRIDS Capital has built a diverse portfolio that supports innovation in various industries, including artificial intelligence and life sciences. Notably, they have participated in significant funding rounds for biotechnology companies such as BigHat Biosciences, which raised $75 million to enhance its AI/ML-wet lab platform and advance therapeutic programs. Additionally, they have invested in Recursion Pharmaceuticals and Senti Biosciences, both of which are involved in pharmaceutical development. These transactions highlight GRIDS Capital's active role in the life sciences sector, making them a relevant player in the pharmaceutical manufacturing landscape.


5. Eretz.bio

  • Website: eretz.bio
  • Type: Corporate
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2017
  • Headcount: 11-50
  • Number of deals in 2024: 16
  • LinkedIn: eretz.bio

Eretz.bio is a not-for-profit organization based in Sao Paulo, Brazil, founded in 2017. It serves as an innovation hub associated with the Hospital Israelita Albert Einstein, focusing on incubating startups in the healthcare sector. Eretz.bio provides resources and support to help these startups develop innovative solutions, particularly in biotechnology, digital health, and medical devices. In 2024, Eretz.bio has been involved in several transactions relevant to the pharmaceutical manufacturing context, including investments in Pangea Bio and RadBio, both of which are in the seed stage, as well as Speratum Biopharma, Inc., which raised funds in a venture round. These activities demonstrate Eretz.bio's active role in fostering innovation in the pharmaceutical and biotechnology sectors.


6. Cites

  • Website: cites-gss.com
  • Type: Venture Capital
  • Headquarters: Sunchales, Santa Fe, Argentina
  • Founded year: 2014
  • Headcount: 51-200
  • Number of deals in 2024: 2
  • LinkedIn: cites

Cites is a venture capital firm based in Sunchales, Santa Fe, Argentina, founded in 2014. The firm specializes in supporting the development of scientific and technological startups, providing venture capital investment, mentorship, and access to resources for early-stage companies. Cites has been involved in several relevant transactions in the pharmaceutical manufacturing context, including a significant investment in Eolo Pharma, which raised US$2.7 million in a Series A round to develop new anti-obesity drugs. This funding is aimed at advancing drug trials to human testing, showcasing Cites' commitment to the pharmaceutical sector. Additionally, Cites has invested in ARDAN PHARMA and other biotech startups, further solidifying their role in the pharmaceutical manufacturing landscape.


7. Aurus

  • Website: aurus.cl
  • Type: Venture Capital
  • Headquarters: Lo Barnechea, Santiago, Chile
  • Founded year: 2008
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn: aurus

Aurus is a venture capital firm based in Lo Barnechea, Santiago, Chile, founded in 2008. The firm partners with entrepreneurs and startups, providing strategic advisory, recruitment, and crisis management services to help high-potential businesses navigate challenges and achieve growth. Aurus has been involved in several transactions, notably with Algenis, a company that has raised funds multiple times since 2012, indicating a sustained interest in the biotechnology sector. Additionally, they invested in Andes Biotechnologies, which raised funds in a Series B round in December 2014. These transactions highlight Aurus's commitment to supporting companies that are relevant to pharmaceutical manufacturing and biotechnology, making them a noteworthy player in this investment space.


8. Zentynel Frontier Investments


Zentynel Frontier Investments is a venture capital firm based in Santiago, Chile, founded in 2017. The firm specializes in biotechnology investments, providing financial backing and management expertise to innovative startups in the sector. Zentynel focuses on high-growth potential companies, helping them navigate the challenges of funding and market entry. In 2024, they participated in notable transactions such as Xeptiva Therapeutics, which raised $2.5 million in a seed round, and Asclepii, which raised $500,000 in another seed round. These investments reflect their commitment to supporting companies that may play a role in pharmaceutical manufacturing and biotechnology development.


9. Veronorte

  • Website: veronorte.com
  • Type: Venture Capital
  • Headquarters: Sabanalarga, Antioquia, Colombia
  • Founded year: 2012
  • Headcount: 1-10
  • LinkedIn: veronorte

Veronorte is a venture capital firm based in Sabanalarga, Antioquia, Colombia, founded in 2012. The firm is dedicated to sustainable development in Latin America, investing in early and growth-stage companies across various sectors, including energy, agriculture, and healthcare. Veronorte aims to facilitate access to sustainable opportunities and help businesses navigate the regional market effectively. Notably, they have participated in significant funding rounds for biotechnology companies such as Nuritas, which focuses on innovative health solutions, and Viome, which specializes in health diagnostics and personalized nutrition. These investments highlight Veronorte's engagement in the healthcare and pharmaceutical sectors, aligning with their mission to drive value and innovation in industries that contribute to sustainable development.


10. Fen Ventures

  • Website: fenventures.com
  • Type: Venture Capital
  • Headquarters: Las Condes, Santiago, Chile
  • Founded year: 2012
  • Headcount: 1-10
  • Number of deals in 2024: 5
  • LinkedIn: fen-ventures

Fen Ventures is a venture capital firm based in Las Condes, Santiago, Chile, founded in 2012. The firm specializes in investing in early-stage startups within the Latin American tech sector, providing not only capital but also strategic support and networking opportunities to entrepreneurs. In 2024, Fen Ventures has made notable investments, including a $2.5 million seed round in Xeptiva Therapeutics, a company likely focused on therapeutic innovations. They also participated in a $2.1 million investment round for Bioeutectics, which is developing green solvents that may have applications in pharmaceutical manufacturing. Additionally, they were involved in the seed funding round for Michroma, a company that could be working on biotechnological solutions relevant to the pharmaceutical industry. These transactions highlight Fen Ventures' engagement with companies that have potential implications in the pharmaceutical manufacturing sector, despite their broader focus on technology.


11. Nexxus Capital


Nexxus Capital is a private equity investment firm based in Mexico City, Mexico, founded in 1995. The firm specializes in private equity and mezzanine debt for mid-sized companies primarily in Mexico and Spain. Nexxus Capital manages multiple funds aimed at providing capital to help businesses grow and expand their operations. Among their notable transactions, they have invested in Genomma Lab, a company involved in the pharmaceutical and personal care sectors, raising an undisclosed amount in a private equity round in 2003. Additionally, they participated in a post-IPO equity round for Immunotec, a company that focuses on health and wellness products, including those with pharmaceutical applications, in 2017. These transactions highlight Nexxus Capital's engagement with the pharmaceutical manufacturing industry, making them a relevant player in this space.


12. Fundo Criatec


Fundo Criatec is a venture capital firm based in Sao Paulo, Brazil, founded in 2007. The fund operates across various sectors, including biotechnology, which is pertinent to the pharmaceutical industry. It has facilitated investments in companies such as Rizoflora Biotechnology, which raised $1,111,000 in a venture round in 2008, and BR3 Agrobiotecnologia, which raised $535,202 in a Series A round in 2009. These transactions highlight the fund's engagement in biotechnology, a field that often intersects with pharmaceutical manufacturing. Additionally, the fund has invested in Imeve, which raised $1,425,582 in 2011, although the specific relevance to pharmaceuticals is less clear. Overall, Fundo Criatec provides innovative solutions to businesses in health and biotechnology, making it a potential player in the pharmaceutical manufacturing landscape.


13. big_bets

  • Website: bigbets.com.br
  • Type: Venture Capital
  • Headquarters: Sao Paulo, Sao Paulo, Brazil
  • Founded year: 2019
  • Headcount: 1-10
  • Number of deals in 2024: 10
  • LinkedIn:

big_bets is an investment and consulting agency based in Sao Paulo, Brazil, founded in 2019. They specialize in partnering with entrepreneurs to support the development of technology startups, providing investment consulting, mentoring, and strategic guidance to help early-stage companies navigate challenges and achieve growth. In 2023, big_bets was involved in notable transactions, including a seed round investment in Menten AI, which focuses on artificial intelligence applications, and a significant participation in Pepper Bio, a drug discovery startup that raised $6.5 million. This involvement in Pepper Bio highlights their interest in the pharmaceutical manufacturing sector, as they support companies that are innovating in drug development and discovery.


14. Clave Capital

  • Website: clavecapital.com.br
  • Type: Venture Capital
  • Headquarters: Jardim Paulista, Sao Paulo, Brazil
  • Founded year: 2021
  • Headcount: 11-50
  • Number of deals in 2024: 1
  • LinkedIn: clavecapital

Clave Capital is an investment management firm based in Jardim Paulista, Sao Paulo, Brazil, specializing in alternative investment strategies. Founded in 2021, the firm manages a range of funds focused on equity, credit, and real estate investments. Clave Capital aims to provide effective asset management and financial growth for its clients, which include both businesses and individual investors. Notably, Clave Capital has participated in significant funding rounds within the pharmaceutical sector, including a €6.7M investment in OneChain Immunotherapeutics, which is focused on developing innovative immunotherapeutic solutions. Additionally, they were involved in funding MiMARK Diagnostics, which is advancing in vitro diagnostic assays for endometrial cancer. These transactions highlight Clave Capital's engagement in the pharmaceutical manufacturing space, showcasing their commitment to supporting healthcare innovation.


15. WAMEX Private Equity

  • Website: wamex.mx
  • Type: Corporate
  • Headquarters: Mexico City, Mexico City, Mexico
  • Founded year: 1999
  • Headcount: 11-50
  • LinkedIn: wamex-private-equity

WAMEX Private Equity is a private equity firm based in Mexico City, founded in 1999. The firm specializes in investments in middle-market companies across various sectors, including healthcare, energy, and real estate. They provide financial and strategic advisory services to help businesses grow and navigate market challenges. Notably, WAMEX has invested in Productos Medix, S.A., which raised $32 million in a private equity round in January 2013, highlighting their engagement in the pharmaceutical manufacturing sector. Additionally, their portfolio includes companies like Hoteles City Express and KUA Mex Foods, showcasing their diverse investment strategy while maintaining a significant presence in healthcare-related investments.


16. Carao Ventures

  • Website: caraov.com
  • Type: Venture Capital
  • Headquarters: Costa Rica
  • Founded year: 2012
  • Headcount: 1-10
  • Number of deals in 2024: 3
  • LinkedIn: carao-ventures

Carao Ventures is a venture capital firm based in Costa Rica, founded in 2012, that focuses on early-stage investments in innovation-driven companies across Latin America. The firm aims to support entrepreneurs with the technical skills and determination to disrupt industries by providing them with the necessary funding and resources to grow their businesses. Notably, Carao Ventures has been involved in significant transactions within the pharmaceutical sector, including investments in Speratum Biopharma, Inc., where they participated in both a seed round and a convertible note, raising a total of $2.8 million. Additionally, they participated in a Series C financing round for Levita Magnetics, a company that, while primarily focused on health technology, is involved in regulatory and commercial efforts that intersect with the pharmaceutical manufacturing landscape. These transactions highlight Carao Ventures' engagement in the pharmaceutical industry, reinforcing their role as a relevant investor in this sector.


17. Invariantes Fund


Invariantes Fund is a venture capital fund founded in 2015, based in Guatemala, that specializes in investing in early-stage startups across the US and Latin America. The fund provides not only capital but also strategic support, helping startups connect with potential clients and investors. Their focus is primarily on technology-driven companies, particularly in software and hardware sectors. Notably, Invariantes Fund has participated in transactions such as the Series B funding for Immusoft, a gene therapy startup that is working on treatments for genetic disorders like Hurler's Syndrome. This investment highlights their engagement in the pharmaceutical sector, particularly in innovative therapeutic technologies, showcasing their potential relevance in the pharmaceutical manufacturing landscape.



Pharmaceutical Manufacturing Insights: Key Investors in Latin America


InvestorHeadquarterSizeFoundedDeals 2024
bossa investSao Paulo, Sao Paulo, Brazil11-50201156
KptlSao Paulo, Sao Paulo, Brazil11-5020205
The Ganesha LabLas Condes, Santiago, Chile1-1020165
GRIDS CapitalSao Paulo, Sao Paulo, Brazil1-1020161
Eretz.bioSao Paulo, Sao Paulo, Brazil11-50201716
CitesSunchales, Santa Fe, Argentina51-20020142
AurusLo Barnechea, Santiago, Chile11-5020081
Zentynel Frontier InvestmentsSantiago, Santiago, Chile1-1020174
VeronorteSabanalarga, Antioquia, Colombia1-1020120
Fen VenturesLas Condes, Santiago, Chile1-1020125
Nexxus CapitalMexico City, Mexico City, Mexico11-5019950
Fundo CriatecSao Paulo, Sao Paulo, Brazil11-5020070
big_betsSao Paulo, Sao Paulo, Brazil1-10201910
Clave CapitalJardim Paulista, Sao Paulo, Brazil11-5020211
WAMEX Private EquityMexico City, Mexico City, Mexico11-5019990
Carao VenturesCosta Rica1-1020123
Invariantes FundGuatemala1-1020153


Want to find more investors focusing on the pharmaceutical manufacturing industry?

If you want to find more investors that are active in the pharmaceutical manufacturingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!